Rapid Onset of Nucleolar Segregation Followed by DNA Fragmentation in Roscovitine-Treated MCF-7 Cells Supports Its Pro-Apoptotic Potential

por Kotala, V., Horky, M., Uldrijan, S., Strnad, M., Vojtesek, B.
Publicado en ScientificWorldJournal (2001)

Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibition

por Pastorek, M., Muller, P., Coates, P. J., Vojtesek, B.
Publicado en PLoS One (2018)

Biochemical analysis of the stress protein response in human oesophageal epithelium

por Hopwood, D, Moitra, S, Vojtesek, B, Johnston, D, Dillon, J, Hupp, T
Publicado 1997

Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique.

por Vojtĕsek, B., Fisher, C. J., Barnes, D. M., Lane, D. P.
Publicado 1993

HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours.

por Bártek, J., Petrek, M., Vojtĕsek, B., Bártková, J., Kovarík, J., Rejthar, A.
Publicado 1987

Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer

por Kolář, Z, Murray, P G, Scott, K, Harrison, A, Vojtěšek, B, Dušek, J
Publicado 2000

Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers...

por Craig, A L, Burch, L, Vojtesek, B, Mikutowska, J, Thompson, A, Hupp, T R
Publicado 1999

TAp63gamma is required for the late stages of myogenesis

por Cefalù, S, Lena, AM, Vojtesek, B, Musarò, A, Rossi, A, Melino, G, Candi, E
Publicado en Cell Cycle (2015)

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.

por Fisher, C. J., Gillett, C. E., Vojtĕsek, B., Barnes, D. M., Millis, R. R.
Publicado 1994

Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos.

por Lichnovský, V, Kolár, Z, Murray, P, Hlobilková, A, Cernochová, D, Pospísilová, E, Vojtĕsek, B, Nenutil, R
Publicado 1998

Absence of p53 autoantibodies in a significant proportion of breast cancer patients.

por Vojtesek, B., Kovarik, J., Dolezalova, H., Nenutil, R., Havlis, P., Brentani, R. R., Lane, D. P.
Publicado 1995

Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines

por Mad’arová, J, Lukešová, M, Hlobilková, A, Strnad, M, Vojtěšek, B, Lenobel, R, Hajdúch, M, Murray, P G, Perera, S, Kolář, Z
Publicado 2002

p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration

por Turnquist, C, Horikawa, I, Foran, E, Major, E O, Vojtesek, B, Lane, D P, Lu, X, Harris, B T, Harris, C C
Publicado en Cell Death Differ (2016)

A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.

por Speiser, P., Gharehbaghi-Schnell, E., Eder, S., Haid, A., Kovarík, J., Nenutil, R., Sauter, G., Schneeberger, C. H., Vojtesek, B., Wiltschke, C. H., Zeillinger, R.
Publicado 1996

Identification and role of migration stimulating factor isoforms in breast carcinomas

por Schor, AM, Ellis, IR, Jones, SJ, Perrier, S, Florence, MM, Cox, J, Ohe, G, Kankova, K, Vojtesek, B, Thompson, AM, Purdie, C, Kazmi, S, Foo, S, Woolston, AM, Schor, SL
Publicado 2008